London
08048030295
+917498304432

LuciMob (Mobocertinib) in London, Washington USA, Canberra Australia, Singapore and Manila Philippines

LuciMob is used for treating EGFR exon 20 insertion mutation-positive lung cancer.

Active Ingredient

Mobocertinib targets EGFR exon 20 mutations.

Uses of LuciMob

• EGFR exon 20 NSCLC

How LuciMob Works

Inhibits abnormal EGFR signaling pathways.

How to Use LuciMob

• Take as prescribed

Possible Side Effects

• Diarrhea
• Rash

Precautions

• Monitor heart rhythm

Safety Information

Requires medical supervision.

Storage

• Store at room temperature
• Keep away from moisture
• Keep out of reach of children

 2026-03-19T05:23:34

Other Pages

View all pages